Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 7, 2025 | (Q2)Jun 15, 2025 | (Q1)Mar 23, 2025 | (FY)Dec 29, 2024 | (Q4)Dec 29, 2024 | (Q3)Sep 8, 2024 | (Q2)Jun 16, 2024 | (Q1)Mar 24, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||||||
| Cash flow from continuing operating activities | -36.24%17.2M | -23.76%4.79M | -95.71%507K | 223.05%61.23M | 16.15M | 26.98M | 6.29M | 11.81M | 18.95M |
| Net income from continuing operations | 170.71%17.56M | 42.42%12.53M | 23.26%9.26M | -42.97%21.68M | ---1.11M | --6.49M | --8.8M | --7.51M | --38.01M |
| Operating gains losses | 151.64%1.22M | 117.97%552K | 93.45%-182K | 16.22%-9.72M | ---1.51M | ---2.35M | ---3.07M | ---2.78M | ---11.6M |
| Depreciation and amortization | 0.14%1.44M | 15.10%1.62M | 16.27%1.56M | 24.25%6.23M | --2.03M | --1.44M | --1.41M | --1.34M | --5.01M |
| Asset impairment expenditure | ---- | ---6K | ---22K | -653.49%-238K | ---- | ---- | --0 | --0 | --43K |
| Remuneration paid in stock | ---2K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | --459K | --528K | --70K | ---- | ---- | --0 | --0 | --0 | ---- |
| Deferred tax | 143.88%6.05M | 165.76%4.67M | 62.77%3.19M | 211.69%28.27M | --22.08M | --2.48M | --1.76M | --1.96M | --9.07M |
| Other non cashItems | -32.77%5.79M | -67.39%3.2M | 345.19%3.26M | 164.72%5.24M | ---11.85M | --8.61M | --9.81M | ---1.33M | ---8.1M |
| Change In working capital | -207.77%-7.09M | 6.71%-9.25M | -137.05%-2.58M | 376.69%15.24M | --11.63M | --6.57M | ---9.92M | --6.96M | ---5.51M |
| -Change in receivables | -164.27%-2.26M | -71.73%-13.68M | 38.50%7.13M | -343.03%-1.81M | ---2.52M | --3.52M | ---7.97M | --5.15M | ---409K |
| -Change in inventory | 95.88%-195K | 158.99%2.34M | 10.62%3.68M | 15.94%2.27M | --7.65M | ---4.74M | ---3.97M | --3.33M | --1.96M |
| -Change in prepaid assets | -23.12%1.05M | 35.42%-558K | 170.22%1.6M | -11.11%-1.1M | ---2.2M | --1.37M | ---864K | --591K | ---990K |
| -Change in payables and accrued expense | -188.49%-5.68M | -8.06%2.65M | -610.19%-14.99M | 361.84%15.88M | --8.69M | --6.42M | --2.88M | ---2.11M | ---6.07M |
| Interest paid (cash flow from operating activities) | -8,150.00%-3.47M | -3,508.59%-4.62M | -1,799.53%-4.03M | -212.96%-1.11M | ---730K | ---42K | ---128K | ---212K | ---355K |
| Interest received (cash flow from operating activities) | -81.31%20K | -71.76%24K | 231.82%73K | 127.27%425K | --211K | --107K | --85K | --22K | --187K |
| Tax refund paid | -230.48%-4.79M | -81.25%-4.46M | -509.36%-10.09M | 38.61%-4.79M | ---4.35M | --3.67M | ---2.46M | ---1.66M | ---7.81M |
| Cash from discontinued investing activities | |||||||||
| Operating cash flow | -36.24%17.2M | -23.76%4.79M | -95.71%507K | 223.05%61.23M | --16.15M | --26.98M | --6.29M | --11.81M | --18.95M |
| Investing cash flow | |||||||||
| Cash flow from continuing investing activities | -107.32%-194K | -123.53%-625K | -308.41%-719K | -3,384.12%-168.38M | -174.03M | 2.65M | 2.66M | 345K | 5.13M |
| Net PPE purchase and sale | -115.77%-164K | 67.10%-76K | 74.26%-122K | 104.88%146K | ---189K | --1.04M | ---231K | ---474K | ---2.99M |
| Net intangibles purchas and sale | 88.14%-30K | ---549K | -15.84%-446K | 36.00%-1.93M | ---1.29M | ---253K | --0 | ---385K | ---3.01M |
| Dividends received (cash flow from investment activities) | --0 | --0 | --0 | -14.32%9.54M | --2.56M | --2.89M | --2.89M | --1.2M | --11.13M |
| Net other investing changes | ---- | ---- | ---151K | ---176.13M | ---175.11M | ---1.02M | ---- | ---- | ---- |
| Cash from discontinued investing activities | |||||||||
| Investing cash flow | -107.32%-194K | -123.53%-625K | -308.41%-719K | -3,384.12%-168.38M | ---174.03M | --2.65M | --2.66M | --345K | --5.13M |
| Financing cash flow | |||||||||
| Cash flow from continuing financing activities | -1.14%-12.41M | 37.63%-12.39M | -313.88%-11.39M | 598.09%125.83M | 160.72M | -12.27M | -19.87M | -2.75M | -25.26M |
| Net issuance payments of debt | 90.77%-866K | 86.23%-875K | -370.66%-11.39M | 3,703.12%181.41M | --199.56M | ---9.38M | ---6.36M | ---2.42M | --4.77M |
| Cash dividends paid | -509.15%-11.52M | -27.02%-11.52M | ---- | -49.42%-28.24M | ---17.28M | ---1.89M | ---9.07M | ---- | ---18.9M |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---- | ---12.52M | ---- | ---- | ---- | ---- | --0 |
| Net other financing activities | 97.69%-23K | ---- | ---- | -33.12%-14.82M | ---9.04M | ---997K | ---4.45M | ---332K | ---11.13M |
| Cash from discontinued financing activities | |||||||||
| Financing cash flow | -1.14%-12.41M | 37.63%-12.39M | -313.88%-11.39M | 598.09%125.83M | --160.72M | ---12.27M | ---19.87M | ---2.75M | ---25.26M |
| Net cash flow | |||||||||
| Beginning cash position | 16.23%2.71M | -17.54%10.93M | 484.54%22.53M | -23.47%3.86M | --19.69M | --2.33M | --13.26M | --3.86M | --5.04M |
| Current changes in cash | -73.51%4.6M | 24.74%-8.23M | -223.39%-11.6M | 1,680.29%18.68M | --2.85M | --17.36M | ---10.93M | --9.4M | ---1.18M |
| End cash Position | -62.90%7.31M | 16.23%2.71M | -17.54%10.93M | 484.54%22.53M | --22.53M | --19.69M | --2.33M | --13.26M | --3.86M |
| Free cash from | -36.16%17.01M | -31.17%4.17M | -100.56%-61K | 350.36%58.32M | --14.68M | --26.64M | --6.06M | --10.95M | --12.95M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.